demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
hydroxychloroquine plus macrolides Rosenberg Carlucci Sbidian ... Lagier Arshad ... Davido Duke university HCQ-AZI Magagnoli ... Huang
azithromycin plus hydroxychloroquine ProPAC-COVID Coalition Covid-19 Brazil I ...

1 studies excluded by filtering options 2

5375 Mehra, 2020 2133excludednot a RCThigh risk of bias